Compounding Pharmacies Market – Global Industry Analysis and Forecast (2022–2027)

Compounding Pharmacies Market is expected to reach US$ 11.71 Bn. at a CAGR of 4%  during the forecast period 2027. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology:-Request Free Sample Report Favourable demographic inclinations towards improved life expectancy coupled with rising geriatric population will render substantial positive impact on Global Compounding Pharmacies Market growth. Patient of old age normally needs dosage forms and drug excipients that are unalike from commercially available products in market. In such circumstances, compounded medications tailor-made to individual needs allow superior handling of disease conditions. As a result, growing number of geriatric population will boost the market for compounded medications. Dearth of availability of skilled workforce coupled with high cost of sophisticated equipment required for compounding medicines might hamper the market growth by 2024. Continuously, changing regulations will further hinder the industry growth affecting the production of compounded drugs on large scale. Lack of timely availability of customary drugs will lead the demand for compounded medications. Shortage of drugs might have severe repercussion such as death of patients. For instance, Europe and North America region have witnessed substantial drug shortage over past few years. Oral product segment from Global Compounding Pharmacies Market accounted for highest market share in 2017. The high market value is owed to the growing demand for compounded oral medicine, particularly in the domain of pain management. Additionally, the oral liquid dosage forms are favoured due to associated ease of administration and convenience. Geriatric people time and again desire liquid oral dosage form in auxiliary to commercially available dosage forms. Adult application segment will show a robust growth over the upcoming years. Increasing prevalence of cardiovascular, respiratory oncology, viral, and bacterial diseases in adult population will mainly boost the segment growth. Women over the age of 40years suffering from hormonal changes in their body require compounded hormonal medications. This will additionally support the segment growth over the forecast timeframe.

Compounding Pharmacies Market Scope: Inquire before buying

Global Compounding Pharmacies Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2027
Historical Data: 2017 to 2021 Market Size in 2021: US $ 9.25 Bn.
Forecast Period 2022 to 2027 CAGR: 4 % Market Size in 2027: US $ 11.71 Bn.
Segments Covered: by Product • Oral o Solid preparations  Tablets  Capsules  Granules  Powder  Others o Liquid preparations  Solutions  Suspension  Emulsion  Syrup  Others • Topical o Ointments o Creams o Gels o Pastes o Others • Rectal o Suppositories o Edema o Others • Parenteral • Inhaler • Ophthalmic o Eye drops o Ear drops o Nasal drops o Others
by Application •Pediatrics •Adult •Geriatric •Veterinary Therapeutic Area •Hormone Replacement •Pain Management

The above data will be provided for following regions/countries  (USD Million)

• North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia Global Compounding Pharmacies Market,Key Players • B. BraunAthenex Pharma Solutions • Fresenius Kabi • Clinigen Group PLC • Dougherty's Pharmacy, Inc. • Fagron • Lorraine’s Pharmacy • Institutional Pharmacy Solutions • McGuff Company Inc. • Nephron Pharmaceuticals Corporation • Rx3 Compounding Pharmacy • Wedgewood Village Pharmacy, Inc. • Pencol Compounding Pharmacy • Triangle Compounding Pharmacies • Wedgewood Village Pharmacy, Inc. • PharMEDium Services, LLC • Cantrell Drug Company • Elixir Compounding Pharmacy • Avella specialty pharmacy • US Compounding Inc • Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd Frequently Asked Questions: 1] What segments are covered in the Compounding Pharmacies Market report? Ans. The segments covered in the Compounding Pharmacies Market report are based on Product and application. 2] Which region is expected to hold the highest share in the Compounding Pharmacies Market? Ans. The Asia Pacific region is expected to hold the highest share in the Compounding Pharmacies Market. 3] What is the market size of the Compounding Pharmacies Market by 2027? Ans. The market size of the Compounding Pharmacies Market by 2027 is US$ 11.71 Bn. 4] What is the forecast period for the Compounding Pharmacies Market? Ans. The forecast period for the Compounding Pharmacies Market is 2022-2027. 5] What was the market size of the Compounding Pharmacies Market in 2021? Ans. The market size of the Compounding Pharmacies Market in 2021 was US$ 9.25 Bn.

Global Compounding Pharmacies Market

Chapter 1 Research Methodology 1.1. Research Methodology 1.2. Market definition 1.3. Assumptions and Acronyms Used 1.4. Data Sources 1.4.1. Secondary 1.4.1.1. Paid 1.4.1.2. Unpaid 1.4.2. Primary Chapter 2 Executive Summary 2.1. Global ambulatory surgery centers market overview 2.1.1. Product 2.1.2. Application 2.1.3. Therapeutic area Chapter 3 Global Compounding Pharmacies Market, Industry Insights 3.1. Market segmentation and scope of study 3.2. Market Drivers and their impact analysis 3.2.1. Market Drivers 3.2.1.1. Increasing geriatric population & longevity globally 3.2.1.2. Growing acceptance of personalized medicines worldwide in U.S. and Europe 3.2.1.3. Increasing drug shortage in North America and Europe 3.2.1.4. Convenience of using compounded drugs 3.2.2. Market restraints 3.2.2.1. Lack of skilled lab technicians and pharmacists in developed countries 3.3. Market share analysis 3.3.1. By product type 3.3.2. By application 3.3.3. By therapeutic area 3.4. Reimbursements scenario 3.4.1. U.S. 3.4.2. Europe 3.5. Regulations landscape 3.5.1. U.S. 3.5.2. Europe 3.6. Competitive analysis 3.6.1. Key strategic initiatives 3.6.2. Regional presence 3.6.3. Product overview 3.7. Porter’s analysis 3.8. PESTEL analysis Chapter 4 Global Compounding Pharmacies Market, By Product Type 4.1. Key segment trends 4.2. Oral 4.2.1. Market size, by region, 2019 – 2026 4.2.2. Solid preparations 4.2.2.1. Market size, by region, 2019 – 2026 4.2.2.2. Tablets 4.2.2.2.1. Market size, by region, 2019 – 2026 4.2.2.3. Capsules 4.2.2.3.1. Market size, by region, 2019 – 2026 4.2.2.4. Granules 4.2.2.4.1. Market size, by region, 2019 – 2026 4.2.2.5. Powder 4.2.2.5.1. Market size, by region, 2019 – 2026 4.2.2.6. Others 4.2.2.6.1. Market size, by region, 2019 – 2026 4.2.3. Liquid preparations 4.2.3.1. Market size, by region, 2019 – 2026 4.2.3.2. Solutions 4.2.3.2.1. Market size, by region, 2019 – 2026 4.2.3.3. Suspension 4.2.3.3.1. Market size, by region, 2019 – 2026 4.2.3.4. Emulsion 4.2.3.4.1. Market size, by region, 2019 – 2026 4.2.3.5. Syrup 4.2.3.5.1. Market size, by region, 2019 – 2026 4.2.3.6. Others 4.2.3.6.1. Market size, by region, 2019 – 2026 4.3. Topical 4.3.1. Market size, by region, 2019 – 2026 4.4. Rectal 4.4.1. Market size, by region, 2019 – 2026 4.4.2. Suppositories 4.4.2.1. Market size, by region, 2019 – 2026 4.4.3. Edema 4.4.3.1. Market size, by region, 2019 – 2026 4.4.4. Others 4.4.4.1. Market size, by region, 2019 – 2026 4.5. Parenteral 4.5.1. Market size, by region, 2019 – 2026 4.6. Inhaler 4.6.1. Market size, by region, 2019 – 2026 4.7. Ophthalmic 4.7.1. Market size, by region, 2013 – 2024 4.7.2. Eye drops 4.7.2.1. Market size, by region, 2013 – 2024 4.7.3. Ear drops 4.7.3.1. Market size, by region, 2013 – 2024 4.7.4. Nasal drops 4.7.4.1. Market size, by region, 2013 – 2024 4.7.5. Others 4.7.5.1. Market size, by region, 2013 – 2024 4.7.5.2. Key Trends in Global Compounding Pharmacies Market 5.1. Key segment trends 5.2. Pediatrics 5.2.1. Market size, by region, 2019 – 2026 5.3. Adult 5.3.1. Market size, by region, 2019 – 2026 5.4. Geriatric 5.4.1. Market size, by region, 2013 – 2024 5.5. Veterinary 5.5.1. Market size, by region, 2013 – 2024 Chapter 6 Global Compounding Pharmacies Market, By Therapeutic Area 6.1. Key segment trends 6.2. Hormone Replacement 6.2.1. Market size, by region, 2019 – 2026 6.3. Pain Management 6.3.1. Market size, by region, 2019 – 2026 Chapter 7 Global Compounding Pharmacies Market, By Region 7.1. Key regional trends 7.2. North America 7.2.1. Market size, by country, 2013 – 2024 7.2.2. Market size, by product type, 2013 – 2024 7.2.3. Market size, by application, 2013-2014 7.2.4. Market size, by therapeutic area, 2013-2014 7.2.5. U.S. 7.2.5.1. Market size, by product type, 2013 – 2024 7.2.5.2. Market size, by application, 2013-2014 7.2.5.3. Market size, by therapeutic area, 2013 – 2024 7.2.6. Canada 7.2.6.1. Market size, by product type, 2013 – 2024 7.2.6.2. Market size, by application, 2013-2014 7.2.6.3. Market size, by therapeutic area, 2013 – 2024 7.3. Europe 7.3.1. Market size, by country, 2013 – 2024 7.3.2. Market size, by product type, 2013 – 2024 7.3.3. Market size, by application, 2013-2014 7.3.4. Market size, by therapeutic area, 2013 – 2024 7.3.5. Germany 7.3.5.1. Market size, by product type, 2013 – 2024 7.3.5.2. Market size, by application, 2013-2014 7.3.5.3. Market size, by therapeutic area, 2013 – 2024 7.3.6. UK 7.3.6.1. Market size, by product type, 2013 – 2024 7.3.6.2. Market size, by application, 2013-2014 7.3.6.3. Market size, by therapeutic area, 2013 – 2024 7.3.7. France 7.3.7.1. Market size, by product type, 2013 – 2024 7.3.7.2. Market size, by application, 2013-2014 7.3.7.3. Market size, by therapeutic area, 2013 – 2024 7.3.8. Spain 7.3.8.1. Market size, by product type, 2013 – 2024 7.3.8.2. Market size, by application, 2013-2014 7.3.8.3. Market size, by therapeutic area, 2013 – 2024 7.3.9. Italy 7.3.9.1. Market size, by product type, 2013 – 2024 7.3.9.2. Market size, by application, 2013-2014 7.3.9.3. Market size, by therapeutic area, 2013 – 2024 7.3.10. Russia 7.3.10.1. Market size, by product type, 2013 – 2024 7.3.10.2. Market size, by application, 2013-2014 7.3.10.3. Market size, by therapeutic area, 2013 – 2024 7.4. Asia Pacific 7.4.1. Market size, by country, 2013 – 2024 7.4.2. Market size, by product type, 2013 – 2024 7.4.3. Market size, by application, 2013-2014 7.4.4. Market size, by therapeutic area, 2013 – 2024 7.4.5. India 7.4.5.1. Market size, by product type, 2013 – 2024 7.4.5.2. Market size, by application, 2013-2014 7.4.5.3. Market size, by therapeutic area, 2013 – 2024 7.4.6. China 7.4.6.1. Market size, by product type, 2013 – 2024 7.4.6.2. Market size, by application, 2013-2014 7.4.6.3. Market size, by therapeutic area, 2013 – 2024 7.4.7. Japan 7.4.7.1. Market size, by product type, 2013 – 2024 7.4.7.2. Market size, by application, 2013-2014 7.4.7.3. Market size, by therapeutic area, 2013 – 2024 7.4.8. Australia 7.4.8.1. Market size, by product type, 2013 – 2024 7.4.8.2. Market size, by application, 2013-2014 7.4.8.3. Market size, by therapeutic area, 2013 – 2024 7.5. Latin America 7.5.1. Market size, by country, 2013 – 2024 7.5.2. Market size, By product type, 2013 – 2024 7.5.3. Market size, by application, 2013-2014 7.5.4. Market size, by therapeutic area, 2013 – 2024 7.5.5. Argentina 7.5.5.1. Market size, by product type, 2013 – 2024 7.5.5.2. Market size, by application, 2013-2014 7.5.5.3. Market size, by therapeutic area, 2013 – 2024 7.5.6. Brazil 7.5.6.1. Market size, by product type, 2013 – 2024 7.5.6.2. Market size, by application, 2013-2014 7.5.6.3. Market size, by therapeutic area, 2013 – 2024 7.5.7. Mexico 7.5.7.1. Market size, by product type, 2013 – 2024 7.5.7.2. Market size, by application, 2013-2014 7.5.7.3. Market size, by therapeutic area, 2013 – 2024 7.6. Middle East and Africa 7.6.1. Market size, by country, 2013 – 2024 7.6.2. Market size, by product type, 2013 – 2024 7.6.3. Market size, by application, 2013-2014 7.6.4. Market size, by therapeutic area, 2013 – 2024 7.6.5. South Africa 7.6.5.1. Market size, by product type, 2013 – 2024 7.6.5.2. Market size, by application, 2013-2014 7.6.5.3. Market size, by therapeutic area, 2013 – 2024 7.6.6. Saudi Arabia 7.6.6.1. Market size, by product type, 2013 – 2024 7.6.6.2. Market size, by application, 2013-2014 7.6.6.3. Market size, by therapeutic area, 2013 – 2024 Chapter 8 Consolidations 8.1. Mergers and Acquisitions 8.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements 8.3. Patent Analysis 8.4. Key players 8.4.1. B.Braun Medical 8.4.1.1. Company overview 8.4.1.2. Key financials 8.4.1.3. Product landscape 8.4.1.4. Strategic initiatives 8.4.1.5. SWOT analysis 8.4.2. Cantrell Drug company 8.4.2.1. Company overview 8.4.2.2. Key financials 8.4.2.3. Product landscape 8.4.2.4. Strategic initiatives 8.4.2.5. SWOT analysis 8.4.3. Doughtery’s Pharmacy 8.4.3.1. Company overview 8.4.3.2. Key financials 8.4.3.3. Product landscape 8.4.3.4. Strategic initiatives 8.4.3.5. SWOT analysis 8.4.4. Fagron 8.4.4.1. Company overview 8.4.4.2. Key financials 8.4.4.3. Product landscape 8.4.4.4. Strategic initiatives 8.4.4.5. SWOT analysis 8.4.5. Fresenuis Kabi 8.4.5.1. Company overview 8.4.5.2. Key financials 8.4.5.3. Product landscape 8.4.5.4. Strategic initiatives 8.4.5.5. SWOT analysis 8.4.6. Institutional Pharmacy solutions 8.4.6.1. Company overview 8.4.6.2. Key financials 8.4.6.3. Product landscape 8.4.6.4. Strategic initiatives 8.4.6.5. SWOT analysis 8.4.7. ITC Compounding Pharmacy 8.4.7.1. Company overview 8.4.7.2. Key financials 8.4.7.3. Product landscape 8.4.7.4. Strategic initiatives 8.4.7.5. SWOT analysis 8.4.8. Lorraine’s Pharmacy 8.4.8.1. Company overview 8.4.8.2. Key financials 8.4.8.3. Product landscape 8.4.8.4. Strategic initiatives 8.4.8.5. SWOT analysis 8.4.9. Mcguff compounding pharmacy services 8.4.9.1. Company overview 8.4.9.2. Key financials 8.4.9.3. Product landscape 8.4.9.4. Strategic initiatives 8.4.9.5. SWOT analysis 8.4.10. Pencol Compounding Pharmacy 8.4.10.1. Company overview 8.4.10.2. Key financials 8.4.10.3. Product landscape 8.4.10.4. Strategic initiatives 8.4.10.5. SWOT analysis 8.4.11. PharmMEDium 8.4.11.1. Company overview 8.4.11.2. Key financials 8.4.11.3. Product landscape 8.4.11.4. Strategic initiatives 8.4.11.5. SWOT analysis 8.4.12. Rx3 Compounding Pharmacy 8.4.12.1. Company overview 8.4.12.2. Key financials 8.4.12.3. Product landscape 8.4.12.4. Strategic initiatives 8.4.12.5. SWOT analysis 8.4.13. Triangle compounding Pharmacies 8.4.13.1. Company overview 8.4.13.2. Key financials 8.4.13.3. Product landscape 8.4.13.4. Strategic initiatives 8.4.13.5. SWOT analysis 8.4.14. Village compounding Pharmacies 8.4.14.1. Company overview 8.4.14.2. Key financials 8.4.14.3. Product landscape 8.4.14.4. Strategic initiatives 8.4.14.5. SWOT analysis 8.4.15. Wedgewood Village Pharmacy 8.4.15.1. Company overview 8.4.15.2. Key financials 8.4.15.3. Product landscape 8.4.15.4. Strategic initiatives 8.4.15.5. SWOT analysis

About This Report

Report ID 10228
Category Healthcare
Published Date June 2022
Updated Date
Contact Us